The purpose of this study is to 1) evaluate the safety and efficacy of two doses of bupropion
SR (150mg/day and 300mg/day) when compared to placebo, as an aid to smoking cessation in
adolescents and 2) to examine which factors, such as medication adherence, nicotine
dependence, and motivation to quit, affect treatment outcome.